Mutation

(redirected from Factor V Leiden mutation)
Also found in: Dictionary, Thesaurus, Medical, Acronyms, Encyclopedia.

MUTATION, French law. This term is synonymous with change, and is particularly applied to designate the change which takes place in the property of a thing in its transmission from one person to another; permutation therefore happens when, the owner of the thing sells, exchanges or gives it. It is nearly synonymous with transfer. (q.v.) Merl. Repert. h.t.

Mentioned in ?

References in periodicals archive ?

Activated protein C resistance and factor V Leiden mutation can be associated with first as well as secondtrimester recurrent pregnancy loss.

The association of factor V leiden mutation with recurrent pregnancy loss

Individuals who are heterozygous for the Factor V Leiden mutation carry a risk of venous thrombosis five to seven times higher than that of the general population; homozygous subjects have a risk 80 times higher.

A 52-year-old man with ecchymotic leg ulcers

[36] determined the prevalence of the factor V Leiden mutation in 73 patients with postthrombotic and nonpostthrombotic venous ulcers.

Association between thrombophilia and the post-thrombotic syndrome

(22.) Haslam N, Standen GR, Probert CS: An investigation of the association of the factor V Leiden mutation and inflammatory bowel disease.

Inflammatory bowel disease and thrombosis / Inflamatuvar Bagirsak Hastaligi ve Tromboz

The factor V Leiden mutation is the most frequent cause of familial thrombosis and vWD is the most common inherited bleeding disorder.

A case of a combined commonly inherited bleeding and clotting disorder

Factor V Leiden mutation is present in the 4-6% of the general population and is the most common inherited cause of the syndrome accounting for the 40-50% of cases (1).

Combined heterozygote factor V Leiden mutation and anticardiolipin antibody positivity in a young patient with spontaneous deep vein thrombosis/Kombine heterozigot faktor V Leiden mutasyonu ve antikardiyolipin antikor pozitifligi olan genc bir hastada derin ven trombozu

(16) Since lupus anti coagulant may be a potential interferent in the modified assay, patients with lupus anticoagulant should be evaluated for the factor V Leiden mutation by genetic testing.

Factor V Leiden: an overview

The factor V Leiden mutation is the most common genetic thrombophilia: the heterozygous form, found in 5%-8% of the normal population, increases the risk of VTE five-fold, whereas the rarer homozygous form confers an 18-fold risk increase.

Genetics, OCs up venous thromboembolism risk

American College of Medical Genetics consensus statement on factor V Leiden mutation testing.

From peapods to laboratory medicine: molecular diagnostics of inheritable diseases. (Clinical Issues)

Prothrombin 20210 G: a mutation and Factor V Leiden mutation in women with a history of severe preeclampsia and (H)ELLP syndrome.

Bases geneticas y moleculares de la preeclampsia

Objectives: To determine the frequency of Protein C Protein S (PC and PS) antithrombin deficiency (AT III) and Factor V Leiden mutation (FVL) as a cause of thrombophilia in the patients with venous thromboembolism (VTE) and cerebrovascular accident (CVA).

High prevalence of protein C protein S antithrombin deficiency and Factor V Leiden mutation as a cause of hereditary thrombophilia in patients of venous thromboembolism and cerebrovascular accident